Terrie Curran
2019
In 2019, Terrie Curran earned a total compensation of $3.5M as President and Chief Executive Officer at Phathom Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $23,091 |
|---|---|
| Option Awards | $3,394,338 |
| Salary | $41,667 |
| Total | $3,459,096 |
Curran received $3.4M in option awards, accounting for 98% of the total pay in 2019.
Curran also received $23.1K in non-equity incentive plan and $41.7K in salary.
Rankings
In 2019, Terrie Curran's compensation ranked 3,526th out of 13,971 executives tracked by ExecPay. In other words, Curran earned more than 74.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,526 out of 13,971 | 75th |
Division Manufacturing | 1,277 out of 5,701 | 78th |
Major group Chemicals And Allied Products | 442 out of 2,200 | 80th |
Industry group Drugs | 369 out of 1,886 | 80th |
Industry Pharmaceutical Preparations | 278 out of 1,398 | 80th |
Source: SEC filing on April 8, 2020.
Curran's colleagues
We found three more compensation records of executives who worked with Terrie Curran at Phathom Pharmaceuticals in 2019.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020